Overview

Lubiprostone in Children With Functional Constipation

Status:
Completed
Trial end date:
2016-07-27
Target enrollment:
Participant gender:
Summary
Study to determine if children (6-17 years old) with functional constipation will respond to being treated with lubiprostone for 12 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
Sucampo AG
Sucampo Pharma Americas, LLC
Collaborators:
Sucampo AG
Sucampo Pharma Americas, LLC
Takeda
Treatments:
Lubiprostone